Page last updated: 2024-09-03

troxacitabine and Hepatic Veno Occlusive Disease

troxacitabine has been researched along with Hepatic Veno Occlusive Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Estey, E; Garcia-Manero, G; Giles, F; Kantarjian, H; O'Brien, S1

Trials

1 trial(s) available for troxacitabine and Hepatic Veno Occlusive Disease

ArticleYear
Fatal hepatic veno-occlusive disease in a phase I study of mylotarg and troxatyl in patients with refractory acute myeloid leukemia or myelodysplastic syndrome.
    Acta haematologica, 2002, Volume: 108, Issue:3

    Topics: Acute Disease; Aged; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cytosine; Dioxolanes; Female; Gemtuzumab; Hepatic Veno-Occlusive Disease; Humans; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Sialic Acid Binding Ig-like Lectin 3

2002